Vaccine News: Clinical development [September 23-September 30]

Clinical development Moderna begins pivotal norovirus vaccine trial 30 Sep, 2024 Effects of age and gender on immunogenicity and reactogenicity of SpikoGen recombinant spike protein vaccine: a post-hoc analysis 30 Sep, 2024 Ziresovir Reduces Bronchiolitis in Infants Hospitalized With RSV 27 Sep, 2024 POP Biotechnologies Announces Phase 3 Trial Interim Read more…

Vaccine News: Business [September 23- September 30]

Business Global Non-covid mRNA Vaccine and Therapeutics Market Projected to Reach $1,684.80 Million by 203130 Sep, 2024 Gritstone bio’s SWOT analysis: cancer vaccine maker’s stock faces pivotal moment30 Sep, 2024 Plant-Based Vaccines Market Generated Opportunities30 Sep, 2024 Therapeutic Proteins and Oral Vaccines Market to See Booming30 Sep, 2024 Vaccine Packaging Read more…